PT-141 dosage for men is typically 1.75 mg injected under the skin, but the drug is not FDA-approved for male use. Learn timing, side effects, and safety.
The most commonly cited PT-141 dosage for men is 1.75 mg injected subcutaneously, which is the single dose the FDA approved for premenopausal women under the brand name Vyleesi. Bremelanotide (PT-141) is not FDA-approved for men, so any male use is off-label and should be supervised by a licensed clinician. Most protocols limit dosing to one injection every 24 hours and no more than eight doses per month.
PT-141 activates melanocortin receptors in the brain rather than acting directly on blood flow. That mechanism is why it is usually described as a desire and arousal agent, and it is also why the dose-response curve does not reward taking more.
PT-141 Dosage for Men at a Glance
Male dosing information comes from small early-phase trials, compounded product labels, and community reports rather than a federal prescribing label. The table below summarizes the numbers that come up most often.
| Route | Dose commonly cited for men | Onset | Notes |
|---|---|---|---|
| Subcutaneous injection (FDA-approved Vyleesi) | 1.75 mg | 30-60 minutes | Fixed-dose auto-injector; approved for women only |
| Subcutaneous injection (compounded) | 1-2 mg | 30-60 minutes | Requires reconstitution; purity varies by source |
| Intranasal (discontinued research formulation) | 1.25-10 mg | 15-45 minutes | Studied in men with erectile dysfunction; never approved |
| Maximum frequency | 1 dose per 24 hours | — | Label caps use at 8 doses per month for women |
There is no validated pt-141 peptide dosage for men calculator. Online calculators generally apply the female 1.75 mg label figure or simple body-weight math, and neither approach has been tested in men.
Is There an FDA-Approved PT-141 Dose for Men?
No. The FDA approved bremelanotide in 2019 only for premenopausal women with acquired, generalized hypoactive sexual desire disorder. The label calls for 1.75 mg injected into the abdomen or thigh at least 45 minutes before anticipated sexual activity, with a maximum of one dose every 24 hours and eight doses per month.
Early trials did include men. Researchers testing pt-141 for men with erectile dysfunction reported modest improvements at higher intranasal doses, but the program never led to an approval for male use. That gap is why every male dose figure circulating online is off-label.
Dosing by Route: Injection vs. Nasal Spray
Subcutaneous injection
The Vyleesi auto-injector delivers a fixed 1.75 mg dose and cannot be adjusted. Compounded vials usually arrive as a 10 mg powder that must be reconstituted with bacteriostatic water, which means the user or clinician controls the amount drawn into the syringe.
A vial labeled 10 mg is not a 10 mg dose. If it is reconstituted with 1 mL of water, the pt-141 10mg dosage for men that circulates in forums would mean injecting the entire vial — roughly six times the approved amount and far beyond anything tested in a controlled setting.
Nasal spray and older formulations
Early erectile dysfunction studies used an intranasal spray at doses from 1.25 mg to 10 mg. Anyone comparing a pt-141 nasal spray dosage for men should know that the nasal product was discontinued, absorption was unpredictable, and those numbers do not transfer to compounded injectable versions.
Timing, Onset, and Duration
- Onset: usually 30 to 60 minutes after injection
- Peak effect: about 1 hour after dosing
- Duration: most reports describe 2 to 6 hours of effect
- Half-life: roughly 2.7 hours
Clinicians typically advise dosing 45 to 60 minutes before sexual activity. Taking a second dose the same day does not reliably extend the window and sharply increases the chance of nausea.
Side Effects and Safety Limits
Nausea is the most common complaint, reported by roughly 40 percent of participants in the pivotal trials. Flushing, headache, vomiting, injection site reactions, and short-lived blood pressure increases are also frequent.
PT-141 is contraindicated for people with uncontrolled high blood pressure or known cardiovascular disease. It should not be used alongside medications that raise blood pressure, and it is not recommended for anyone with a history of focal neurological symptoms.
Blood pressure usually returns to baseline within 12 hours, but the spike is real and measurable. Checking blood pressure before starting, and again after a first dose, is a reasonable precaution.
Compounded PT-141 vs. FDA-Approved Vyleesi
| Factor | Vyleesi (bremelanotide) | Compounded PT-141 |
|---|---|---|
| FDA status | Approved for premenopausal women with HSDD | Not FDA-approved |
| Dose control | Fixed 1.75 mg auto-injector | User-measured; depends on reconstitution |
| Purity and potency | Manufactured to label specifications | Varies by supplier; independent testing is rare |
| Prescription needed | Yes | Varies by state and vendor |
The pt-141 dosage for women is standardized at 1.75 mg because the product is regulated. Men using compounded peptide have no equivalent guarantee that a labeled milligram is a real milligram.
What to Discuss With a Healthcare Provider
- Whether an off-label trial makes sense given your cardiovascular history
- Any blood pressure, heart, or migraine medications you take
- Current blood pressure readings and whether they are well controlled
- How a compounded product was sourced and whether a certificate of analysis exists
- Approved options for erectile dysfunction or low desire that already have a label
PT-141 is not a substitute for evaluating the underlying causes of sexual dysfunction, including testosterone levels, vascular health, current medications, and mental health. A clinician can work through those factors alongside any decision about dosing.
Frequently Asked Questions
What is the recommended PT-141 dosage for men?
There is no FDA-approved PT-141 dose for men, because the drug is only approved for premenopausal women with hypoactive sexual desire disorder. Most references cite 1.75 mg injected subcutaneously, the female Vyleesi dose, and off-label male protocols generally stay between 1 mg and 2 mg. Dosing is typically capped at one injection every 24 hours and eight doses per month.
How long before sex should a man take PT-141?
Most guidance points to 45 to 60 minutes before sexual activity. Onset usually occurs within 30 to 60 minutes, the peak effect arrives around the one-hour mark, and most users report effects lasting 2 to 6 hours. Taking a second dose the same day does not reliably extend the effect and increases nausea risk.
Is PT-141 safe for men?
Short-term trials and post-marketing data show common side effects including nausea, flushing, headache, vomiting, and temporary blood pressure increases. PT-141 is contraindicated for people with uncontrolled hypertension or known cardiovascular disease. Long-term safety data specific to men using compounded PT-141 does not exist, so medical supervision matters.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.